Equities

SoftMedx Healthcare Ltd

SoftMedx Healthcare Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)0.38
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change0.00%
  • Beta0.0000
Data delayed at least 15 minutes, as of Nov 17 2017.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SoftMedx Healthcare Ltd, formely China Wah Yan Healthcare Ltd, is an investment holding company principally engaged in the medical and healthcare businesses. The Company operates through three segments. The Medical and Well-being segment is engaged in the operation of medical centres specialising in the diagnosis and treatment of tumour. The Segment is also engaged in the operation of optical products and eye-care services retail shops. The Segment is also engaged in the manufacturing and sale of pharmaceutical and health related products. In addition, the Segment is engaged in the provision of medical laboratory testing services, health check services and obstetric and gynaecological services. The Health Management segment is engaged in the operation of sports and healthcare clubhouses. The Asset Management segment is engaged in the investment in financial assets, fixed assets and distressed assets, as well as loan financing.

  • Revenue in HKD (TTM)193.87m
  • Net income in HKD-133.72m
  • Incorporated1989
  • Employees120.00
  • Location
    SoftMedx Healthcare Ltd36th Floor, Times Tower391-407 Jaffe RoadWanchai Hong KongHKG
  • Phone+852 21873085
  • Fax+852 21873570
  • Websitehttp://www.648.com.hk/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CA Cultural Technology Group Ltd342.75m-842.39m37.83m239.00------0.1104-0.7127-0.71270.29-0.80570.448758.064.011,138,691.00-110.44-22.85---36.901.9220.58-246.16-80.020.0979-1.0910.83---20.49-14.781.58---36.84--
SoftMedx Healthcare Ltd193.87m-133.72m123.89m120.00--0.8562--0.6391-0.4101-0.41010.59460.44380.2759.2313.57---18.97-23.88-36.31-42.2330.9739.12-68.98-139.860.8045-0.50790.7149---0.17827.6057.06------
Okura Holdings Ltd323.20m215.47m228.00m381.000.97260.65790.91980.70540.39070.39070.5690.57760.348858.99530.75848,298.9023.25-4.4027.98-5.1311.08-14.3166.67-13.671.21--0.5595--12.98-6.34343.7534.08-24.75--
Niraku GC Holdings Inc1.30bn35.17m316.90m1.57k9.010.30761.310.24380.02940.02021.090.86170.384361.13213.42869,884.500.9837-1.571.19-1.9421.0318.802.56-4.370.97493.140.6706--11.59-1.37196.02---10.6515.77
Data as of Nov 17 2017. Currency figures normalised to SoftMedx Healthcare Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Meeschaert Asset Management SAas of 14 Sep 202360.000.00%
Data from 29 Sep 2023 - 29 Sep 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.